Dutch molecular diagnostics company with an infectious disease testing platform usable at room temperature without electricity.
| Date | Round | Amount |
|---|---|---|
| Sep 2025 | Grant Rapidemic received a $2.7 million grant from the Gates Foundation to develop its molecular diagnostics platform for sexually transmitted infections. | $2.7M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.